These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population. Pierreux J; Bravenboer B Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209 [TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden. Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754 [TBL] [Abstract][Full Text] [Related]
8. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134 [TBL] [Abstract][Full Text] [Related]
9. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study. Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677 [TBL] [Abstract][Full Text] [Related]
10. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. Rubin MR; Bilezikian JP; McMahon DJ; Jacobs T; Shane E; Siris E; Udesky J; Silverberg SJ J Clin Endocrinol Metab; 2008 Sep; 93(9):3462-70. PubMed ID: 18544625 [TBL] [Abstract][Full Text] [Related]
11. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Silverberg SJ; Lewiecki EM; Mosekilde L; Peacock M; Rubin MR J Clin Endocrinol Metab; 2009 Feb; 94(2):351-65. PubMed ID: 19193910 [TBL] [Abstract][Full Text] [Related]
13. Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk. Lewiecki EM; Miller PD J Clin Densitom; 2013; 16(1):28-32. PubMed ID: 23374738 [TBL] [Abstract][Full Text] [Related]
14. Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism? Traini E; Bellantone R; Tempera SE; Russo S; De Crea C; Lombardi CP; Raffaelli M Langenbecks Arch Surg; 2018 May; 403(3):317-323. PubMed ID: 29541851 [TBL] [Abstract][Full Text] [Related]
15. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism. Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327 [TBL] [Abstract][Full Text] [Related]
16. Current opinions on nephrolithiasis associated with primary hyperparathyroidism. Cong X; Shen L; Gu X Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243 [TBL] [Abstract][Full Text] [Related]
17. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism. Yankova I; Lilova L; Petrova D; Dimitrova I; Stoynova M; Shinkov A; Kovatcheva R Endocrine; 2024 Jul; 85(1):341-346. PubMed ID: 38489132 [TBL] [Abstract][Full Text] [Related]
18. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment. Dawood NB; Tseng CH; Nguyen DT; Yan KL; Livhits MJ; Leung AM; Yeh MW J Clin Endocrinol Metab; 2021 Nov; 106(12):e4993-e5000. PubMed ID: 34313755 [TBL] [Abstract][Full Text] [Related]
19. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism. Lewiecki EM J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971 [TBL] [Abstract][Full Text] [Related]
20. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Paruk IM; Esterhuizen TM; Maharaj S; Pirie FJ; Motala AA Postgrad Med J; 2013 Nov; 89(1057):626-31. PubMed ID: 23824345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]